TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.03
+0.03 (+1.50%)
Open$2.02
Previous Close$2.00
Day High$2.09
Day Low$1.99
52W High$2.95
52W Low$0.98
Volume—
Avg Volume97.5K
Market Cap22.57M
P/E Ratio126.09
EPS$0.02
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+485.2% upside
Current
$2.03
$2.03
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.02M | 8.62M | 4.86M |
| Net Income | -569,458 | -1,460,564 | 1.27M |
| Profit Margin | -18.8% | -17.9% | 26.2% |
| EBITDA | -4,008,201 | -10,851,498 | 2.17M |
| Free Cash Flow | — | — | 1.08M |
| Rev Growth | -64.9% | -64.9% | +8.5% |
| Debt/Equity | — | — | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |